Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor

Stroke. 2006 Apr;37(4):1094-9. doi: 10.1161/01.STR.0000206444.29930.18. Epub 2006 Mar 2.

Abstract

Background and purpose: Hypoxia preconditioning (HPC), rapid or delayed, has been reported to induce neuroprotection against subsequent severe stress. Because delta-opioid receptor (DOR) plays an important role in delayed HPC-induced neuroprotection against severe hypoxic injury, we asked whether DOR is also involved in the rapid HPC-induced neuroprotection.

Methods: Cultured rat cortical neurons at culture days 8 to 9 were exposed to a short-term hypoxia (1% O2 for 30 minutes) to induce HPC followed by 30-minute normoxia before exposing to glutamate toxicity (100 micromol/L; 4 hours). Neuronal viability was assessed by lactate dehydrogenase leakage and morphological assessment. Protein and mRNA levels of DOR were detected by receptor binding and RT-PCR, respectively. Naltrindole was used to block DOR. Developmental changes in NMDA receptor expression was measured by Western blots.

Results: HPC significantly reduced the glutamate-induced neuronal injury. Receptor binding showed that HPC increased DADLE (a DOR ligand) binding density in the cultured cortical neurons by >90% over control level (P<0.05), although RT-PCR did not detect any appreciable change in DOR mRNA. DOR inhibition with naltrindole had no effect on neuronal injury and completely abolished the HPC-induced neuroprotection. In contrast to HPC-induced increase in DADLE binding density, prolonged hypoxia caused severe neuronal injury with a significant decrease in DADLE binding density and DOR mRNA level.

Conclusions: DOR is involved in neuroprotection induced by rapid HPC in cortical neurons.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cells, Cultured
  • Cellular Senescence
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / metabolism
  • Enkephalin, Leucine-2-Alanine / metabolism
  • Glutamic Acid / poisoning*
  • Hypoxia / physiopathology*
  • Ischemic Preconditioning*
  • L-Lactate Dehydrogenase / metabolism
  • N-Methylaspartate / metabolism
  • Naltrexone / analogs & derivatives
  • Naltrexone / pharmacology
  • Narcotic Antagonists / pharmacology
  • Neurons / drug effects*
  • Neurons / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Receptors, Opioid, delta / antagonists & inhibitors
  • Receptors, Opioid, delta / genetics
  • Receptors, Opioid, delta / metabolism*
  • Time Factors
  • Up-Regulation

Substances

  • Narcotic Antagonists
  • RNA, Messenger
  • Receptors, Opioid, delta
  • Glutamic Acid
  • Naltrexone
  • Enkephalin, Leucine-2-Alanine
  • N-Methylaspartate
  • L-Lactate Dehydrogenase
  • naltrindole